Devyser Diagnostics AB () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

BONESUPPORT HOLDING AB

MedCap AB

Devyser Diagnostics AB

Doxa AB

Xvivo Perfusion AB

CellaVision AB

Surgical Science Sweden AB

Sedana Medical AB

Smart Eye AB

Genovis AB

Bactiguard Holding AB

Why is Devyser Diagnostics AB ?

The company has declared positive results for the last 4 consecutive quarters

OPERATING CASH FLOW(Y) Highest at SEK 31.7 MM
PRE-TAX PROFIT(Q) At SEK 4.4 MM has Grown at 751.85%
NET PROFIT(Q) At SEK 2.9 MM has Grown at 238.1%

With ROE of -2.37%, it has a risky valuation with a 3.74 Price to Book Value

Over the past year, while the stock has generated a return of -25.56%, its profits have risen by 86.3%

Underperformed the market in the last 1 year

Even though the market (OMX Stockholm 30) has generated returns of 30.13% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -25.56% returns

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Devyser Diagnostics AB should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Devyser Diagnostics AB for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Devyser Diagnostics AB

-25.56%

-0.52

41.09%

OMX Stockholm 30

30.13%

1.89

15.95%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

27.99%

EBIT Growth (5y)

25.65%

EBIT to Interest (avg)

-31.88

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

0.59

Tax Ratio

3.56%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.74

EV to EBIT

116.90

EV to EBITDA

35.87

EV to Capital Employed

4.34

EV to Sales

5.04

PEG Ratio

Dividend Yield

ROCE (Latest)

3.71%

ROE (Latest)

-2.37%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

20What is working for the Company

OPERATING CASH FLOW(Y)

Highest at SEK 31.7 MM

PRE-TAX PROFIT(Q)

At SEK 4.4 MM has Grown at 751.85%

NET PROFIT(Q)

At SEK 2.9 MM has Grown at 238.1%

ROCE(HY)

Highest at 4.36%

-3What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at -7.35 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.31 times

Here's what is working for Devyser Diagnostics AB

Pre-Tax Profit

At SEK 4.4 MM has Grown at 751.85%

over average net sales of the previous four periods of SEK -0.67 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (SEK MM)

Net Profit

At SEK 2.9 MM has Grown at 238.1%

over average net sales of the previous four periods of SEK -2.1 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (SEK MM)

Operating Cash Flow

Highest at SEK 31.7 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Depreciation

Highest at SEK 7.5 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for Devyser Diagnostics AB

Debt-Equity Ratio

Highest at -7.35 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 1.31 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio